Aptose Biosciences remains steady as it navigates recent developments.
Aptose Biosciences Inc (APS.TO) has seen no significant price movement this week, maintaining its last close at C$2.40. With a year-to-date increase of approximately 18.81%, the stock has held steady amid a backdrop of recent corporate developments.
Investor takeaway: Investors should note the completion of Aptose's acquisition by Hanmi Pharmaceutical and the recent presentation of clinical data, which may influence the stock's performance going forward. However, the absence of immediate news suggests a wait-and-see approach.
Advertisement
Aptose Biosciences Inc
APS.TO
APS.TO
Aptose Biosciences Inc
WealthAwesomeMarket cap
$6.13M
52W high
$2.59
52W low
$1.41
1W change
+0.00%
Beta
0.34
Analyst Price Targets
Based on analyst covering APS
Wall Street analysts forecast APS stock price to fall 1.7% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.36
-1.7% Upside
Current Price
C$2.40
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APS's historical volatility
30-Day Vol
52.7%
Annualized
90-Day Vol
48.9%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$2.40
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.40 | C$2.00 – C$2.88 |
| 60 trading days | C$2.40 | C$1.86 – C$3.10 |
| 90 trading days | C$2.40 | C$1.75 – C$3.29 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$2.40 – Current Price of Aptose Biosciences Inc
Aptose’s current price is within 84% of its 52-week range of C$1.41 to C$2.59, indicating relative stability in a volatile market.
Bull case
The acquisition by Hanmi Pharmaceutical could give Aptose more resources to advance its clinical trials, which might lead to future growth.
Bear case
Aptose faces significant financial challenges, including a negative return on equity and no profit margin, which could deter potential investors.
Current Price Action
Aptose Biosciences Inc (APS.TO) closed at C$2.40, showing no change in price over the past day. Over the past week, the stock has also remained flat, reflecting a lack of major catalysts driving movement.
Recent Company Developments
Advertisement
Recent headlines highlight the completion of Aptose's acquisition by Hanmi Pharmaceutical and the presentation of clinical data at the 2026 EHA Congress. These developments may set the stage for future growth, although the lack of immediate financial news means investors should proceed cautiously.
Technical Picture
From a technical standpoint, Aptose is trading above its 50-day moving average of C$2.25 and its 200-day moving average of C$2.14, indicating a positive trend in the short to medium term. With a 52-week trading range of C$1.41 to C$2.59, the stock has performed well, currently sitting at 84% of its range. The stock has a low beta of 0.34, suggesting less volatility compared to the market.
Volume Analysis
The latest trading volume for Aptose was 2,945 shares, which is slightly below the 20-day average volume of 3,425 shares, indicating a quieter trading environment. This lower volume may suggest a lack of strong interest from investors at this time.
Insider Activity
No recent insider activity has been reported for Aptose Biosciences, which may indicate stability in the management and ownership structure following the acquisition.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
